![Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-5469158-150x150.jpg "Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp] 16")
Law and Politics: Why Marijuana Rescheduling’s One-Sided Hearing Matters
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustryMental HealthAnxietyPain Why This Matters Marijuana rescheduling could alter clinical…
Cannabis for Tourette Tics: What the Meta-Analysis Does and Does Not Prove
A 2026 systematic review and meta-analysis reported reductions in tic severity and premonitory urges with cannabis-based medicines in Tourette syndrome. The signal is promising, but the evidence base is still small, mixed, and not enough to settle…
Cannabinoids for Alzheimer’s Agitation: What a New Meta-Analysis Adds
A new systematic review and meta-analysis found lower agitation and neuropsychiatric symptom scores with cannabinoid-based therapies in Alzheimer’s disease, but the evidence remains limited by small trials, heterogeneous products, short follow-up, and…
Oral CBD and Blood Pressure: What a New Systematic Review Really Shows
A June 2026 systematic review examined whether oral CBD changes blood pressure in adults. The signal is interesting, especially under stress and during sleep, but the trials were small, short, and too heterogeneous to treat CBD as a blood-pressure…
Will South Carolina Finally Legalize Medical Cannabis?
✦ New CED Clinical Relevance #57 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyPainMental HealthAnxietyCancerNeurologySafety Why This Matters South Carolina’s potential medical cannabis…
For decades, marijuana has been classified by the federal government as a Schedule I drug …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryTHCCBDHemp Why This Matters Rescheduling cannabis from Schedule I to Schedule III would…
Marijuana Rescheduling DEA Judge Violates the Constitution? DEA Is Holding a ALJ …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustrySafetyMental HealthAnxietyPain Clinical Summary # Clinical Summary A constitutional challenge has…
What sets research-led cannabis developers apart?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchIndustryCBDTHCSafetyPolicyNeurology Clinical Summary # Summary Research-led cannabis developers like Oxford…
When sleep becomes the hardest part of managing a chronic condition – leafie
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SleepPainAnxietyNeurologyResearchSafetyPolicy Why This Matters Clinicians managing chronic pain or other conditions…
Policy Watch: 20 Regulatory Updates — June 22, 2026
Policy WatchJune 22, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…